HVC

Healthcare Value Capital Portfolio holdings

AUM $38.5M
This Quarter Return
+3.03%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$49.4M
AUM Growth
+$49.4M
Cap. Flow
-$17.7M
Cap. Flow %
-35.85%
Top 10 Hldgs %
90.12%
Holding
33
New
4
Increased
6
Reduced
2
Closed
8

Top Buys

1
AZN icon
AstraZeneca
AZN
$1.76M
2
AMRI
Albany Molecular Research Inc
AMRI
$1.63M
3
PFE icon
Pfizer
PFE
$1.56M
4
AORT icon
Artivion
AORT
$1.42M
5
QLTI
QLT Inc
QLTI
$1.4M

Top Sells

1
ANIP icon
ANI Pharmaceuticals
ANIP
$9.9M
2
AGN
Allergan plc
AGN
$7.24M
3
TWM icon
ProShares UltraShort Russell2000
TWM
$4.95M
4
BIS icon
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.41M
5
CLVS
Clovis Oncology, Inc.
CLVS
$1.13M

Sector Composition

1 Healthcare 85.45%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AMRI
1
DELISTED
Albany Molecular Research Inc
AMRI
$9.74M 17.8% 598,200 +100,000 +20% +$1.63M
AZN icon
2
AstraZeneca
AZN
$248B
$7.04M 12.86% 100,000 +25,000 +33% +$1.76M
TEVA icon
3
Teva Pharmaceuticals
TEVA
$21.1B
$5.75M 10.51% 100,000 – –
DGX icon
4
Quest Diagnostics
DGX
$20.3B
$5.18M 9.46% 77,208 – –
PFE icon
5
Pfizer
PFE
$141B
$4.67M 8.54% 150,000 +50,000 +50% +$1.56M
TWM icon
6
ProShares UltraShort Russell2000
TWM
$34.5M
$3.96M 7.24% 100,000 -125,000 -56% -$4.95M
LGND icon
7
Ligand Pharmaceuticals
LGND
$3.15B
$2.66M 4.86% 50,000 – –
AORT icon
8
Artivion
AORT
$2.07B
$2.27M 4.14% 200,000 +125,000 +167% +$1.42M
SRNE
9
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.82M 3.32% 180,479 -60,489 -25% -$609K
QLTI
10
DELISTED
QLT Inc
QLTI
$1.4M 2.57% +350,000 New +$1.4M
ARIA
11
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.03M 1.88% 150,000 +50,000 +50% +$344K
RIGL icon
12
Rigel Pharmaceuticals
RIGL
$697M
$908K 1.66% 400,000 – –
CYTK icon
13
Cytokinetics
CYTK
$4.23B
$801K 1.46% +100,000 New +$801K
ALIM
14
DELISTED
Alimera Sciences, Inc.
ALIM
$554K 1.01% +100,000 New +$554K
VIRX
15
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$510K 0.93% 200,000 +175,000 +700% +$446K
FCSC
16
DELISTED
Fibrocell Science Inc.
FCSC
$409K 0.75% 157,769 – –
STML
17
DELISTED
Stemline Therapeutics, Inc.
STML
$281K 0.51% 16,464 – –
IMNN icon
18
Imunon
IMNN
$15M
$233K 0.43% 100,000 – –
CPRX icon
19
Catalyst Pharmaceutical
CPRX
$2.52B
$149K 0.27% +50,000 New +$149K
AMRN
20
Amarin Corp
AMRN
$311M
– – 0 – –
ANIP icon
21
ANI Pharmaceuticals
ANIP
$2.03B
– – -350,000 Closed -$9.9M
BIS icon
22
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.47M
– – -200,000 Closed -$2.41M
BMY icon
23
Bristol-Myers Squibb
BMY
$96B
– – 0 – –
MRK icon
24
Merck
MRK
$210B
– – 0 – –
CLVS
25
DELISTED
Clovis Oncology, Inc.
CLVS
– – -25,000 Closed -$1.13M
1
2